Page last updated: 2024-11-04

temozolomide and Aneuploid

temozolomide has been researched along with Aneuploid in 1 studies

Research Excerpts

ExcerptRelevanceReference
"If metastatic prostate cancer gets resistant to antiandrogen therapy, there are few treatment options, because prostate cancer is not very sensitive to cytostatic agents."1.35High-resolution flow cytometry: a suitable tool for monitoring aneuploid prostate cancer cells after TMZ and TMZ-BioShuttle treatment. ( Braun, K; Didinger, B; Ehemann, V; Mueller, G; Pipkorn, R; Waldeck, W; Wiessler, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, K1
Ehemann, V1
Wiessler, M1
Pipkorn, R1
Didinger, B1
Mueller, G1
Waldeck, W1

Other Studies

1 other study available for temozolomide and Aneuploid

ArticleYear
High-resolution flow cytometry: a suitable tool for monitoring aneuploid prostate cancer cells after TMZ and TMZ-BioShuttle treatment.
    International journal of medical sciences, 2009, Nov-18, Volume: 6, Issue:6

    Topics: Aneuploidy; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; DNA, Neoplasm; Drug De

2009